Description
Book SynopsisThe Pharmaceutical Studies Reader is an engaging survey of the field that brings together provocative, multi-disciplinary scholarship examining the interplay of medical science, clinical practice, consumerism, and the healthcare marketplace.
Trade Review"...provides an in-depth look at the machinery that enables the continued expansion of pharmaceutical products, markets, and subjects." -
Ellen Rubinstein for Anthropology Book Forum, Anthropology NewsTable of ContentsAcknowledgements vii
1 Introduction 1
Jeremy A. Greene and Sergio Sismondo
Part I Pharmaceutical Lives 17
2 The Pharmaceuticalisation of Society? A Framework for Analysis 19
Simon J. Williams, Paul Martin and Jonathan Gabe
3 Pharmaceutical Witnessing: Drugs for Life in an Era of Direct]to]Consumer Advertising 33
Joseph Dumit
Part II New Drugs, Diseases, and Identities 49
4 Releasing the Flood Waters: Diuril and the Reshaping of Hypertension 51
Jeremy A. Greene
5 DepRession and Consumtion: Psychopharmaceuticals, Branding, and New Identity Practices 70
Nathan Greenslit
6 BiDil: Medicating the Intersection of Race and Heart Failure 87
Anne Pollock
7 Manufacturing Desire: The Commodification of Female Sexual Dysfunction 106
Jennifer R. Fishman
Part III Drugs and the Circulation of Medical Knowledge 121
8 Following the Script: How Drug Reps Make Friends and Influence Doctors 123
Adriane Fugh]Berman and Shahram Ahari
9 Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster 133
Kalman Applbaum
10 Pushing Knowledge in the Drug Industry: Ghost]Managed Science 150
Sergio Sismondo
11 Transcultural Medicine: A Multi]Sited Ethnography on the Scientific]Industrial Networking of Korean Medicine 165
Jongyoung Kim
Part IV Political and Moral Economies of Pharmaceutical Research 179
12 Uncommon Trajectories: Steroid Hormones, Mexican Peasants, and the Search for a Wild Yam 181
Gabriela Soto Laveaga
13 “Ready]to]Recruit” or “Ready]to]Consent” Populations? Informed Consent and the Limits of Subject Autonomy 195
Jill A. Fisher
14 Clinical Trials Offshored: On Private Sector Science and Public Health 208
Adriana Petryna
15 The Experimental Machinery of Global Clinical Trials: Case Studies from India 222
Kaushik Sunder Rajan
Part V Intellectual Property in Local and Global Markets 235
16 Intellectual Property and Public Health: Copying of HIV/AIDS Drugs by Brazilian Public and Private Pharmaceutical Laboratories 237
Maurice Cassier and Marilena Correa
17 Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis’ Anti]Cancer Drug Glivec 247
Stefan Ecks
18 Generic Medicines and the Question of the Similar 261
Cori Hayden
Index 268
